NORTH HIGHLANDS, CA – October 22, 2025 – PRESSADVANTAGE –
APS Environmental, a leading environmental services provider in the Greater Sacramento area, has enhanced its residential sewer line repair capabilities with advanced trenchless technologies and comprehensive diagnostic tools designed to minimize property disruption while maximizing system longevity.
The company’s expanded residential services address growing concerns about aging infrastructure in Sacramento neighborhoods, where many homes face deteriorating sewer systems that require immediate attention. Through a combination of trenchless repair methods, hydro jetting, and CCTV pipe inspection technology, the company now offers homeowners solutions that avoid traditional excavation challenges.
“Property owners throughout Sacramento are discovering that modern sewer line repair doesn’t require destroying their landscaping or driveways,” said B. Hage, operations director at APS Environmental. “Our trenchless approach allows us to rehabilitate damaged pipes from the inside out, completing most residential repairs in a single day while preserving the property’s exterior appearance.”
The enhanced service portfolio addresses multiple residential needs including septic tank maintenance, hydro excavation for utility location, and comprehensive sewer line replacement when necessary. Each service begins with detailed camera inspections that identify specific problems within the sewer line, allowing technicians to develop targeted repair strategies.
Trenchless technology represents a significant advancement in residential plumbing services. Rather than excavating entire sections of property, technicians can access damaged pipes through small entry points, inserting specialized equipment that repairs or relines pipes from within. This method reduces repair time by up to 70 percent compared to traditional excavation methods.
The company’s hydro jetting services complement these repair capabilities by providing high-pressure water cleaning that removes years of accumulated debris, tree roots, and mineral deposits. This preventive maintenance approach helps homeowners avoid emergency repairs and extends the lifespan of existing sewer systems.
“Residential properties in Sacramento face unique challenges with clay soil conditions and mature tree populations that can compromise underground utilities,” noted Hage. “Our combination of hydro excavation and precision repair techniques addresses these regional concerns while protecting surrounding landscaping and hardscaping investments.”
Beyond individual home services, the company’s residential division supports real estate transactions through pre-sale inspections and documentation. These assessments provide buyers and sellers with detailed reports on sewer system conditions, helping facilitate smooth property transfers.
The expansion of residential services reflects broader industry trends toward sustainable infrastructure management. By extending the functional life of existing sewer systems through advanced repair techniques, property owners can defer costly full replacements while maintaining reliable wastewater management.
APS Environmental maintains 24/7 emergency response capabilities for residential customers facing urgent sewer system failures. The company’s fleet of specialized vehicles, including vacuum trucks and hydro excavation units, enables rapid response to minimize property damage during critical situations.
Established as a licensed environmental services provider, APS Environmental serves the Greater Sacramento region with comprehensive wastewater management solutions. The company specializes in both residential and commercial applications, offering services ranging from routine maintenance to complex pipeline rehabilitation projects. Their technical capabilities include CCTV pipe inspections, GIS coding for infrastructure mapping, and specialized cleaning services for various wastewater systems.
###
For more information about APS Environmental, contact the company here:
APS Environmental Bryan Hage 916-348-2800 info@apsenvironmental.com 6643 32nd St #101, North Highlands, CA 95660
LAS VEGAS, NV – November 08, 2025 – PRESSADVANTAGE –
Cobalt Keys LLC, a Las Vegas-based public relations and communications services firm, announces its expanded focus on helping professional corporations establish market authority through advanced artificial intelligence automation and strategic digital marketing services. The company has positioned itself as one of the few certified partners of both Clay.com and Instantly.ai, offering businesses a path to growth without traditional advertising expenses.
The announcement comes as businesses increasingly seek alternatives to costly paid advertising campaigns while still maintaining competitive market positions. Cobalt Keys LLC’s approach combines artificial intelligence with strategic Email Marketing to help companies achieve measurable growth and revenue goals. The firm’s methodology centers on analyzing online presence gaps that give competitors advantages, then deploying targeted solutions to address these vulnerabilities.
“Businesses today face unprecedented challenges in standing out in crowded markets, and traditional advertising methods are becoming both more expensive and less effective,” said Cynthia Hoyt, Partner at Cobalt Keys LLC. “Our certification partnerships with leading AI platforms allow us to deliver sophisticated automation solutions that most marketing firms simply cannot match. We’re seeing clients achieve significant Brand Exposure and market dominance without spending a single dollar on paid advertisements.”
The company’s comprehensive service portfolio addresses multiple aspects of digital presence and growth. Their AI solutions analyze business online footprints to identify strategic opportunities, while their Content Marketing strategies create engaging materials designed to convert leads into customers. This integrated approach ensures that every client interaction remains targeted and conversion-focused.
The company’s client-centric approach tailors every strategy to meet specific business needs and goals. Rather than applying generic solutions, Cobalt Keys LLC develops customized marketing plans designed to establish robust online assets that bolster visibility and solidify brand presence. This methodology has proven particularly effective for professional corporations and executives seeking to establish themselves as industry authorities.
Cobalt Keys LLC’s certification as a partner with both Clay.com and Instantly.ai represents a significant achievement in the email marketing industry. These partnerships provide the company with advanced tools and methodologies that enhance their ability to deliver measurable results for clients. The firm leverages these platforms to create personalized, data-driven campaigns that resonate with target audiences and drive engagement.
Beyond email and AI automation, the firm offers comprehensive services including organic traffic generation, media coverage acquisition, and strategic brand development. Their systems and processes are designed to scale effectively with company growth and brand exposure, ensuring that marketing efforts remain aligned with business expansion.
Cobalt Keys LLC operates from Las Vegas, Nevada, serving businesses across various industries. The company specializes in brand awareness, public relations, media relations, brand journalism, video marketing, and business consulting. Their team combines technical expertise with strategic insight to help businesses navigate the complexities of modern digital marketing while avoiding the escalating costs of traditional advertising methods.
###
For more information about Cobalt Keys LLC, contact the company here:
Cobalt Keys LLC Cynthia Hoyt (888) 262-2589 contact@cobaltkeys.com 220 EMERALD VISTA WAY #670 LAS VEGAS NV 89144
RENO, NV / ACCESS Newswire / November 5, 2025 / Pershing Resources Company, Inc. (“Pershing” or the “Company”) (OTC PINK:PSGR) is pleased to announced that, as of September 1, 2025, it has paid the U.S. Bureau of Land Management (“BLM”) annual maintenance fees to secure mineral rights for its 4 square mile Mohave Project (gold and silver) north of Kingman, Arizona, and also paid the fees for its 100% owned 11.5 square mile New Enterprise Property, as well as four additional nearby exploration prospects in northwestern Arizona that collectively form the broader New Enterprise Project. These payments permit the Company’s control of these properties through September 1, 2026, when next annual maintenance fees come due. The Company has also renewed its BLM and Esmeralda County claim payments on its 1.6 square mile Klondyke Silver/Gold Property near Tonopah, Nevada, reaffirming Pershing’s commitment to advancing its high-potential portfolio in northwest Arizona and southern Nevada.
“With our BLM obligations behind us, Pershing is now positioned to focus on the next stage of growth,” said COO Joel Adams. “We are actively pursuing private funding to raise funds to commence an initial exploration phase, that will include drill tests, at the promising Mohave Project that should allow us to prepare a SK-1300 compilation report for this property and then, due to its proximity, we also expect to focus on the early-exploration phase as outlined in Pershing’s SK-1300 Technical Report on the New Enterprise Project. Both projects are conveniently located north and south of Kingman Arizona. Pershing’s strategy is to build value through disciplined technical work, while leveraging today’s favorable commodity outlook.”
The New Enterprise Project is underpinned by our conceptual exploration model that integrates remote sensing data (airborne geophysics and satellite imagery) Interpretation of these company owned datasets has identified intriguing areas of overlapping alteration and structural features that were not previously considered features that may have concealed significant mineral potential. A three-phase $2.3M exploration program has been designed to further refine this conceptual model and determine the scope of the interpreted structurally controlled mineralization across the project area as follows:
Phase 1 involves continuation of field mapping, sampling and follow-up ground geophysics estimated to cost $600K,
Phase 2 involves initial drill testing of known mineral occurrences, that have been prioritized in phase 1 by ground geophysics, estimated to cost $700K,
Phase 3 involves follow-up drilling to further prioritize, delineate and assess the size/grade potential of the highest priority occurrence (near surface and to depth), estimated to cost $1M.
The New Enterprise Property is strategically located between two major copper-producing mines the Mineral Park Mine (20 miles northwest) and the Bagdad Mine (45 miles southeast) sitting in the heart of the Laramide Arc, one of North America’s most prolific copper belts. Highlights and details of this intriguing project have been presented in a S-K 1300 technical report summary with an effective date of May 22, 2022 was prepared by an Independent Qualified Person, The New Enterprise Report and Presentation are available on the Company’s website at: https://www.pershingpm.com/projects/the-new-enterprise-project/technical-presentation
To receive additional information on Pershing Resources, sign up for email news alerts at: http://ir.pershingpm.com/
This announcement appears for information purposes only and does not constitute an offer or solicitation of an offer to acquire, purchase or subscribe for any securities of the Company.
Forward-Looking Statements
The information contained in this press release, as well as the information on the Company’s website, is provided solely for the reader’s general knowledge. Such information is not intended to be a comprehensive review of all matters pertaining to the Company. Certain statements included herein, and, on the Company’s, website, constitute “forward-looking statements” within the meaning of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements reflect management’s current knowledge, assumptions, judgment, and expectations regarding future performance or events. Although management believes that the expectations reflected in such statements are reasonable, these forward-looking statements are based on the beliefs of, assumptions made by, and information currently available to the Company’s management. When used in this press release and on the Company’s website, words such as “anticipate,” “believe,” “contemplate,” “continue,” “could,” “estimate,” “expect,” “hope,” “intend,” “may,” “might,” “plan,” “possibility,” “potential,” “predict,” “project,” “should,” “target,” “will,” “would” and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Such forward-looking statements involve known and unknown risks, uncertainties, and other factors that may cause the actual results, performance, and/or achievements of the Company or of the mining industry, in general, to be materially different from future results, performance, and/or achievements expressed or implied by those forward-looking statements. There can be no assurance that such statements will prove to be accurate, and actual results and future events could differ materially from those anticipated in such statements. Important factors that could cause actual results to differ materially from the Company’s expectations include uncertainties related to differences between actual and estimated mineral reserves, fluctuations in gold, silver, copper, and other precious and base metals commodity prices, uncertainties relating to interpretation of drill results and the geology of the Company’s properties, uncertainty of estimates of capital and operating costs, the need for cooperation of government agencies in the development of the Company’s mineral projects, the need to obtain additional financing to develop the Company’s mineral projects, the possibility of delay in development programs or in construction projects, uncertainty of meeting anticipated program milestones for the Company’s mineral projects, the risks associated with the invasion of Ukraine by Russia and other risks and uncertainties affecting the Company’s business operations and financial condition.
All forward-looking statements are expressly qualified in their entirety by this cautionary notice. Readers are cautioned not to place undue reliance on any forward-looking statements, which speak only as of the date of this release. The Company has no obligation, and expressly disclaims any obligation, to update, revise, or correct any of the forward-looking statements.
CONTACT:
Pershing Resources Company, Inc. 200 South Virginia Street, 8th Floor Reno, NV 89501 Phone: 775-398-3124 Email: info.psgr@pershingpm.com
The Sharma Law Firm has announced an expansion of its pedestrian accident legal services in Delaware. The development aims to address the rising number of pedestrian-related incidents across the state, which continue to pose a significant safety concern. The expansion will strengthen the firm’s ability to represent individuals affected by collisions involving motor vehicles and pedestrians, reflecting a growing need for specialized legal guidance in this area.
“Pedestrian safety remains a serious issue in Delaware, and each case requires a focused understanding of both traffic law and injury law,” said Aman Sharma, founder and principal pedestrian accident attorney of The Sharma Law Firm. “Our expansion allows the firm to dedicate additional resources to help ensure that those impacted by pedestrian accidents have access to comprehensive legal representation.”
Recent data indicates that Delaware continues to experience one of the higher rates of pedestrian accidents per capita in the United States. Several factors contribute to this trend, including distracted driving, impaired walking, reckless behavior, and poor visibility conditions. Distracted driving—such as texting or using a cellphone—diverts attention from the road and creates dangerous conditions for pedestrians. Impaired walking, often resulting from alcohol or drug use, can also increase the likelihood of collisions due to reduced judgment and coordination.
Reckless driving behaviors, including speeding and failing to yield at crosswalks, further elevate the risks pedestrians face on Delaware’s roadways. Environmental factors such as low lighting, limited sidewalks, and poor visibility during evening hours add additional layers of risk. The combination of these factors underscores the importance of legal advocacy that not only addresses liability and compensation but also encourages safer roadway practices.
The Sharma Law Firm’s pedestrian accident practice focuses on cases involving collisions at intersections, parking areas, residential zones, and other public spaces where pedestrians are particularly vulnerable. The firm’s approach centers on evidence collection, accident reconstruction, and legal analysis designed to clarify the circumstances of each incident. By expanding this practice area, the firm aims to provide timely representation to those navigating the complex process of filing insurance claims or pursuing legal action after an accident.
Established to serve clients throughout Delaware, The Sharma Law Firm handles a range of personal injury matters including motor vehicle accidents, premises liability, and wrongful death cases. The firm’s office, located at 1007 Orange St., 4th Floor, Wilmington, DE 19801, provides consultations by appointment and maintains direct accessibility to residents in New Castle County and surrounding areas.
Aman Sharma founded the firm to provide structured legal support in cases involving physical injury and financial loss resulting from negligence. The firm’s operations are grounded in thorough case preparation, transparent communication, and compliance with state and federal legal standards. Its expansion in pedestrian accident services aligns with Delaware’s broader focus on traffic safety initiatives, such as crosswalk visibility enhancements and public education campaigns.
The firm also emphasizes the importance of early legal consultation in pedestrian accident cases. Determining liability in such incidents often involves multiple parties, including drivers, municipalities, and insurers. Accurate case evaluation requires an understanding of traffic statutes, local ordinances, and evidentiary procedures. The Sharma Law Firm’s expanded capacity enables its team to handle a higher volume of these cases while maintaining detailed case management and individualized legal support.
As part of its ongoing community engagement, The Sharma Law Firm continues to monitor roadway safety trends and participate in educational outreach designed to raise awareness about pedestrian rights and responsibilities. These initiatives support statewide efforts to reduce pedestrian injuries and fatalities while encouraging collaboration among policymakers, transportation officials, and the public to promote safer environments for all road users.
For additional information about The Sharma Law Firm’s pedestrian accident legal services, visit their website.
###
For more information about The Sharma Law Firm – Wilmington, contact the company here:
The Sharma Law Firm – Wilmington The Sharma Law Firm (302) 781-3077 info@amansharmalaw.com 1007 N Orange St 4th floor Wilmington, DE 19801
SAN DIEGO, CALIFORNIA / ACCESS Newswire / November 6, 2025 / Revelation Biosciences, Inc. (NASDAQ:REVB) (the “Company” or “Revelation”), a clinical-stage life sciences company that is focused on rebalancing inflammation to optimize health, today reported its financial results for the three and nine months ended September 30, 2025.
Corporate Highlights
Announced Groundbreaking Top-line Results from PRIME Clinical Study
Received gross proceeds of $9.6 million from warrant inducement in September 2025
“The outstanding PRIME data and subsequent financing validate Gemini’s potential and places the company on solid footing to advance the next phase of development,” said James Rolke, Chief Executive Officer of Revelation. “We look forward to meeting with the FDA later this year to gain agreement on the clinical development path to registration of Gemini, in turn enhancing shareholder value.”
Results of Operations
As of September 30, 2025, Revelation had $12.7 million in cash and cash equivalents, compared to $6.5 million as of December 31, 2024. The increase in cash and cash equivalents was primarily due to net cash proceeds from the May 2025 public offering and the September 2025 warrant inducement, offset by cash used for operating activities. Based on current operating plans and projections, Revelation believes that its current cash and cash equivalents are sufficient to fund operations through the third quarter of 2026
Revelation’s net cash used for operating activities for the nine months ended September 30, 2025 was $6.3 million compared to net cash used for operating activities of $14.6 million for the same period in 2024. Revelation’s net loss for the three months ended September 30, 2025 was $1.9 million, or $(1.77) basic and diluted net loss per share compared to a net loss of $2.2 million, or $(40.15) basic and diluted net loss per share for the same period in 2024. Revelation’s net loss for nine months ended September 30, 2025 was $6.4 million, or $(9.76) basic and diluted net loss per share compared to net loss of $13.3 million, or $(354.05) basic and diluted net loss per share for the same period in 2024.
About Gemini
Gemini is an intravenously administered, proprietary formulation of phosphorylated hexaacyl disaccharide (PHAD®) that reduces the damage associated with inflammation by reprogramming the innate immune system to respond to stress (trauma, infection, etc.) in an attenuated manner.
Gemini has the potential to treat a wide range of acute and chronic inflammatory conditions. Our primary focus is on the treatment of acute kidney injury (Gemini-AKI) as there are currently no therapies available to treat the large AKI market, and we believe this acute condition will provide the shortest pathway to marketing approval. In addition to AKI, Gemini is being evaluated for the treatment of chronic kidney disease (GEMINI-CKD program), post-burn infection and hyper-inflammatory response (Gemini-PBI) and post-surgical infection (GEMINI-PSI program).
The potential of Gemini has been demonstrated in multiple preclinical studies, previously announced positive Phase 1 clinical data, and in the recently announced positive Phase 1b clinical data in CKD patients.
About Revelation Biosciences, Inc.
Revelation Biosciences, Inc. is a clinical stage life sciences company focused on rebalancing inflammation using its proprietary formulation Gemini. Revelation has multiple ongoing programs to evaluate Gemini, including as a prevention for post-surgical infection, as prevention for acute kidney injury and for the treatment of chronic kidney disease.
This press release contains forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995, as amended. Forward-looking statements are statements that are not historical facts. These forward-looking statements are generally identified by the words “anticipate”, “believe”, “expect”, “estimate”, “plan”, “outlook”, and “project” and other similar expressions. We caution investors that forward-looking statements are based on management’s expectations and are only predictions or statements of current expectations and involve known and unknown risks, uncertainties and other factors that may cause actual results to be materially different from those anticipated by the forward-looking statements. Revelation cautions readers not to place undue reliance on any such forward looking statements, which speak only as of the date they were made. The following factors, among others, could cause actual results to differ materially from those described in these forward-looking statements: the ability of Revelation to meet its financial and strategic goals, due to, among other things, competition; the ability of Revelation to grow and manage growth profitability and retain its key employees; the possibility that the Revelation may be adversely affected by other economic, business, and/or competitive factors; risks relating to the successful development of Revelation’s product candidates; the ability to successfully complete planned clinical studies of its product candidates; the risk that we may not fully enroll our clinical studies or enrollment will take longer than expected; risks relating to the occurrence of adverse safety events and/or unexpected concerns that may arise from data or analysis from our clinical studies; changes in applicable laws or regulations; expected initiation of the clinical studies, the timing of clinical data; the outcome of the clinical data, including whether the results of such study is positive or whether it can be replicated; the outcome of data collected, including whether the results of such data and/or correlation can be replicated; the timing, costs, conduct and outcome of our other clinical studies; the anticipated treatment of future clinical data by the FDA, the EMA or other regulatory authorities, including whether such data will be sufficient for approval; the success of future development activities for its product candidates; potential indications for which product candidates may be developed; the ability of Revelation to maintain the listing of its securities on NASDAQ; the expected duration over which Revelation’s balances will fund its operations; and other risks and uncertainties described herein, as well as those risks and uncertainties discussed from time to time in other reports and other public filings with the SEC by Revelation.
REVELATION BIOSCIENCES, INC. Consolidated Statements of Operations
Three Months Ended September 30,
Nine Months Ended September 30,
2025
2024
2025
2024
Operating expenses:
Research and development
$
922,857
$
830,981
$
3,099,667
$
2,943,492
General and administrative
1,020,154
965,705
3,399,559
3,277,729
Total operating expenses
1,943,011
1,796,686
6,499,226
6,221,221
Loss from operations
(1,943,011
)
(1,796,686
)
(6,499,226
)
(6,221,221
)
Other income (expense):
Change in fair value of warrant liability
611
6,041
2,071
78,884
Other income (expense), net
35,224
(450,920
)
94,512
(7,170,480
)
Total other income (expense), net
35,835
(444,879
)
96,583
(7,091,596
)
Net loss
$
(1,907,176
)
$
(2,241,565
)
$
(6,402,643
)
$
(13,312,817
)
Deemed dividends
(2,769,742
)
–
(5,951,528
)
–
Net loss attributable to common stockholders
$
(4,676,918
)
$
(2,241,565
)
$
(12,354,171
)
$
(13,312,817
)
Net loss per share, basic and diluted
$
(1.77
)
$
(40.15
)
$
(9.76
)
$
(354.05
)
Weighted-average shares used to compute net loss per share, basic and diluted
2,644,733
55,832
1,265,571
37,602
REVELATION BIOSCIENCES, INC. Consolidated Balance Sheets
September 30, 2025
December 31, 2024
ASSETS
Current assets:
Cash and cash equivalents
$
12,708,489
$
6,499,018
Prepaid expenses and other current assets
123,934
66,699
Total current assets
12,832,423
6,565,717
Property and equipment, net
23,919
56,332
Total assets
$
12,856,342
$
6,622,049
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable
$
1,034,951
$
783,621
Accrued expenses
819,381
1,127,800
Warrant liability
175
2,246
Total current liabilities
1,854,507
1,913,667
Total liabilities
1,854,507
1,913,667
Commitments and Contingencies (Note 4)
Stockholders’ equity:
Common Stock, $0.001 par value; 500,000,000 shares authorized at September 30, 2025 and December 31, 2024 and 3,585,972 and 174,104 issued and outstanding at September 30, 2025 and December 31, 2024, respectively
3,586
174
Additional paid-in-capital
57,906,530
45,213,846
Accumulated deficit
(46,908,281
)
(40,505,638
)
Total stockholders’ equity
11,001,835
4,708,382
Total liabilities and stockholders’ equity
$
12,856,342
$
6,622,049
Company Contacts
Mike Porter Investor Relations Porter LeVay & Rose Inc. Email: mike@plrinvest.com
The Light System (TLS) has issued a formal statement regarding the lawsuit filed by Energy Enhancement Systems (EES) against center owner Susan Bowman, as first reported by LA Weekly. TLS affirms its support for Bowman and other practitioners who have invested in light and frequency-based wellness systems in good faith and who now face legal and financial pressure as a result of EES’s actions.
According to LA Weekly, EES filed a lawsuit accusing Bowman of making unauthorized modifications to her system. Bowman has stated that many other center owners made similar adjustments without facing legal action. She believes that the real reason she was targeted is because she spoke publicly about the technology’s origins, pointing to evidence showing that Sandra Rose Michael is not the inventor, and identifying Robert J. Religa as the original creator.
Religa, the documented inventor of the technology, and The Light System, his exclusive distribution partner, have filed a $100 million federal lawsuit against EES in the Eastern District of New York alleging copyright infringement and misrepresentation. That case seeks to protect Religa’s intellectual property rights and to ensure that center owners are treated fairly.
The Light System supports center owners who have acted in good faith and who now find themselves facing legal action they should not have to bear. The Bowman case has drawn significant attention among center owners and industry observers, raising questions about EES’s treatment of its own customers. LA Weekly reported that other owners who made similar modifications were not sued, suggesting a selective legal strategy. Bowman has publicly stated that she was targeted because she discussed documented evidence of the true inventor’s identity, not because of any breach of contract.
TLS’s involvement in the broader legal dispute is centered on defending Religa’s rights as the inventor and protecting practitioners from the consequences of actions that arise from misrepresentation or inconsistent enforcement. The company emphasized its position that legal action should not be used to silence individuals who share factual information or who operate their centers in good faith.
The Light System stated that it will continue to cooperate with legal processes, present evidence where appropriate, and advocate for transparency and accountability in the industry. The company reaffirmed its support for center owners like Susan Bowman and for Robert J. Religa, the original inventor, whose rights are central to the pending federal litigation.
The Light System believes that all parties in this industry should be held to the same standard of truth and fairness. Their focus is to ensure that the facts are clear, that the rights of the inventor are protected, and that practitioners are not punished for seeking or sharing the truth.
Disclaimer: The information provided in this statement is for informational purposes only and reflects The Light System’s position regarding ongoing legal matters. It does not constitute legal advice or a legal determination of liability. All parties are presumed innocent unless and until proven otherwise in a court of law. The Light System makes no medical claims; its technology is not a medical device and is intended solely as a complementary wellness tool.
About The Light System
The Light System (TLS) is a U.S.-based wellness technology company specializing in energy-based systems that may support the body’s natural healing. Rooted in over 30 years of research, TLS combines photonic light collision, sacred geometry, light frequencies, and scalar fields to create immersive environments aimed at promoting clarity, calm, and energetic balance. While not a medical device, TLS is designed as a complementary tool for those exploring the energetic dimensions of well-being. For more information, visit thelightsystems.com and follow the company on Instagram at @thelight.system
###
For more information about The Light System, contact the company here:
The Light System The Light System media@thelightsystems.com
TORONTO, ON / ACCESS Newswire / November 3, 2025 / The Western Investment Company of Canada Limited (TSXV:WI) (“Western“) is pleased to announce the appointment of Keith Lau as Chief Actuary.
Mr. Lau is an accomplished actuarial leader with over ten years of experience in the Canadian property and casualty insurance sector. He brings significant expertise in pricing, reserving and reporting and provides a valuable strategic addition to Western’s growing decentralized insurance platform.
Before joining Western, Mr. Lau served in a range of actuarial roles, most recently as Cover Genius’ Head of Americas Pricing, where he helped to establish and scale the company’s actuarial function in North America. Before his tenure at Cover Genius, Mr. Lau held various roles of escalating responsibility in the actuarial practice at PwC, where he led actuary and audit engagements, played a central role in IFRS 17 implementation and served as a trusted advisor to executive teams on matters related to capital, reserves and solvency. Mr. Lau also spent time at RSA Insurance as a Senior Actuarial Analyst on the pricing team. Mr. Lau holds a Bachelor of Mathematics from the University of Waterloo and is a Fellow of the Casualty Actuarial Society and the Canadian Institute of Actuaries.
As Chief Actuary at Western, Mr. Lau will partner closely with Western’s finance and accounting functions to apply actuarial best practices and ensure compliance with regulatory requirements. Mr. Lau will oversee Western and its subsidiaries’ actuarial operations, including reserving, capital modelling, reviewing and maintaining liquidity, rating and reporting.
“I am delighted to welcome Keith to Western’s executive team. His proven experience across both high-growth businesses and regulated environments aligns strongly with Western’s long-term strategic objectives and will help us to drive Western’s continued success,” said Paul Rivett, Chief Executive Officer of Western.
As part of Mr. Lau’s compensation, Western has agreed to grant 806,452 restricted share units (RSUs) priced at $0.62 per share. Fifty percent of these RSUs will cliff vest after five years, with the balance cliff vesting after 10 years. The grant of these RSUs is subject to approval by the TSXV. It is Western’s expectation that the shares necessary to support these RSUs will be purchased in the open market and will not be issued from treasury.
About The Western Investment Company of Canada Limited
Western is an insurance and investment holding company focused on decentralized ownership of insurance businesses and centralized investment management. Western’s shares are traded on the Toronto Venture Exchange under the symbol WI.
For more information on Western, please visit its website at www.westerninvest.ca.
To add yourself to Western’s email news alert subscription please visit this link.
This news release may contain certain forward-looking information and statements, including without limitation statements pertaining to future results and plans for Western and its associated companies, acquisitions, financings and returns. Statements containing the words: ‘believes’, ‘intends’, ‘expects’, ‘plans’, ‘seeks’ and ‘anticipates’ and any other words of similar meaning are forward-looking. All statements included herein involve various risks and uncertainties because they relate to future events and circumstances beyond Western’s control.
The forward-looking statements are based on certain key expectations and assumptions made by Western, including expectations and assumptions concerning the ability of Western to successfully implement its strategic plans and initiatives.
Although Western believes that the expectations and assumptions on which the forward-looking statements made by Western are based are reasonable, undue reliance should not be placed on the forward-looking statements because no assurance can be provided that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. Actual results could differ materially from those currently anticipated due to a number of factors and risks. These include, but are not limited to, risks relating to regulatory compliance, risks relating to demand for the products and services provided by Fortress Insurance and other portfolio companies, risks relating to future growth prospects and business opportunities, risks that management is not able to execute its business strategy, and the impact of general economic conditions in Canada and the United States. A description of additional assumptions used to develop such forward-looking information and a description of risk factors that may cause actual results to differ materially from forward-looking information can be found in Western’s disclosure documents on the SEDAR+ website at www.sedarplus.com.
The forward-looking statements contained in this news release are made as of the date hereof and Western undertakes no obligation to update publicly or revise any forward-looking statements or information, whether as a result of new information, future events or otherwise, unless so required by applicable securities laws.
This news release shall not constitute an offer to sell or the solicitation of an offer to buy securities in the United States, nor shall there be any sale of the securities in any jurisdiction in which such offer, solicitation or sale would be unlawful.
“Neither the TSX Venture Exchange nor its Regulatory Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.“
SOURCE: The Western Investment Company of Canada Limited
CHERRY HILL, NJ – October 10, 2025 – PRESSADVANTAGE –
All In Solutions Counseling Center Cherry Hill has expanded its comprehensive addiction treatment programs to include an enhanced array of holistic therapies, integrating yoga, meditation, acupuncture, massage therapy, and chiropractic care into its evidence-based treatment protocols. The New Jersey-based addiction treatment center, accredited by the Joint Commission, now offers these complementary modalities alongside its traditional clinical services to address the multifaceted nature of substance abuse recovery.
The expansion reflects a growing recognition in the addiction treatment field that recovery extends beyond traditional therapy sessions to encompass physical, emotional, and spiritual healing. These holistic approaches complement the center’s existing evidence-based treatments, including partial hospitalization programs (PHP), intensive outpatient services (IOP), and outpatient programs (OP).
“Healing is multifaceted. By integrating holistic modalities, we support clients in discovering sustainable paths to wellness that extend far beyond therapy sessions,” said Taylor Justin, Group Facilitator, SW at All In Solutions Counseling Center Cherry Hill. The integration of these therapies aims to empower clients with healthier routines and enhanced emotional resilience throughout their recovery journey.
All In Solutions Counseling Center Cherry Hill’s programs now incorporate yoga therapy and meditation practices designed to help clients develop mindfulness skills and manage stress without substances. Acupuncture services address physical discomfort and withdrawal symptoms, while massage therapy and chiropractic care support the body’s natural healing processes during recovery. These modalities work in conjunction with the center’s trauma-focused therapy, family therapy programs, and specialized tracks for men’s and women’s rehabilitation.
The center maintains its commitment to individualized treatment planning, with each client receiving a customized combination of clinical interventions and holistic therapies based on their specific needs and recovery goals. The expanded offerings complement existing specialized programs, including faith-based treatment options, dual diagnosis treatment for co-occurring mental health conditions, and medication-assisted treatment protocols.
The holistic approach enriches the recovery experience by providing clients with practical tools they can utilize in daily life after completing treatment. This integrative model recognizes that addiction recovery at All In Solutions Counseling Center Cherry Hill involves rebuilding all aspects of an individual’s life, not just addressing substance use behaviors.
All In Solutions Counseling Center operates as part of a behavioral health organization with facilities across multiple states. The Cherry Hill location, situated near Philadelphia and Trenton, provides a full continuum of care ranging from transporation plans from medically supervised detoxification through their outpatient programming. The center’s multidisciplinary team includes medical professionals, licensed therapists, and certified holistic practitioners who collaborate to deliver comprehensive care.
The facility continues to accept various insurance plans and offers assessment services to determine the most appropriate level of care for individuals seeking treatment. The integration of holistic therapies represents an evolution in the center’s approach to addiction treatment, acknowledging that sustainable recovery requires attention to physical wellness, emotional balance, and spiritual growth alongside clinical intervention.
###
For more information about AISOL CH LLC, contact the company here:
All In Solutions Counseling Center Cherry Hill Dennis Ryan (856) 336-5806 admissions@allinsolutions.com All In Solutions Counseling Center Cherry Hill 1930 Marlton Pike East Building T Building S Cherry Hill, NJ 08003, United States
WhiteSands Alcohol & Drug Rehab Orlando has published a new resource titled Accepted Insurances, available on WhiteSandsTreatment.com. The article provides clear, verifiable information about insurance providers accepted at WhiteSands’ treatment centers across Florida. This resource helps patients and families understand how insurance coverage can make addiction treatment more accessible while highlighting the transparency and patient-focused approach that guides WhiteSands’ admissions process.
The publication outlines the range of insurance providers accepted by WhiteSands, including major carriers such as Aetna, Cigna, UnitedHealthcare, Blue Cross Blue Shield, and Humana. By clarifying coverage options, the resource aims to reduce financial uncertainty for patients seeking addiction treatment. Data from the National Institute on Drug Abuse (NIDA) shows that nearly 75% of people struggling with substance use disorders do not receive treatment, often citing financial barriers as one of the primary reasons. WhiteSands’ resource directly addresses this issue by providing clear, factual guidance on how insurance can cover inpatient, outpatient, and intensive outpatient drug rehab programs.
WhiteSands Alcohol & Drug Rehab operates multiple accredited treatment facilities across Florida, including its comprehensive center serving the Orlando area. The Orlando location offers a full continuum of care, including inpatient drug rehab, outpatient programs, and intensive outpatient drug rehab (IOP). The treatment model adheres to evidence-based best practices, aligning with research from the Substance Abuse and Mental Health Services Administration (SAMHSA), which emphasizes the effectiveness of personalized, multi-level treatment plans in enhancing long-term recovery outcomes.
For patients in Downtown Orlando, Thornton Park, and the Central Business District searching for “drug rehab near me” or “best drug rehab centers,” the Orlando facility provides medically supervised detox, residential treatment, and step-down outpatient support. Each level of care is designed to address addiction and co-occurring mental health conditions in a structured yet flexible environment. The program incorporates behavioral therapies such as cognitive-behavioral therapy (CBT) and relapse prevention, consistent with data published by the American Psychological Association showing CBT as one of the most effective therapeutic modalities for substance use disorders.
The resource on accepted insurances also reflects WhiteSands’ broader mission of accessibility and transparency in addiction care. Many treatment centers fail to make financial information readily available, which can discourage people from seeking help. By clearly listing accepted insurance providers and explaining the pre-verification process, the resource helps patients make informed treatment decisions. The organization’s commitment to financial clarity aligns with findings from the National Council for Behavioral Health, which reports that improving transparency in healthcare costs directly increases patient engagement and reduces dropout rates from treatment.
The article also connects insurance acceptance with the continuum of care offered at WhiteSands. For patients who begin with inpatient detox or residential rehab and transition to outpatient or IOP treatment, ongoing insurance coverage ensures continuity of care. This approach aligns with SAMHSA’s guidelines for long-term recovery, which emphasize consistent follow-up and community support. Patients completing treatment in Orlando and nearby areas such as Thornton Park or the Central Business District benefit from individualized discharge plans and aftercare coordination, ensuring stability beyond the initial phase of recovery.
WhiteSands Alcohol & Drug Rehab continues to be recognized for its comprehensive approach to addiction treatment. Its programs integrate medical oversight, therapy, and relapse prevention planning, with outcomes supported by data showing that more extended engagement in structured treatment increases sustained sobriety rates. The National Institute on Alcohol Abuse and Alcoholism (NIAAA) notes that patients who complete full-length residential programs followed by outpatient or IOP care are twice as likely to maintain long-term recovery compared to those who receive shorter or fragmented treatment.
The Accepted Insurances resource further reinforces the organization’s commitment to making treatment accessible without compromising quality. Patients in Downtown Orlando, Thornton Park, and surrounding neighborhoods can use this resource to verify whether their insurance plan covers addiction treatment services before admission. The information complements WhiteSands’ emphasis on patient education, ensuring people understand both the clinical and financial aspects of recovery before beginning care.
By publishing this resource, WhiteSands Alcohol & Drug Rehab contributes to a broader effort to make addiction treatment more transparent, evidence-based, and financially attainable. For patients and families in Orlando searching for “inpatient drug rehab,” “outpatient drug rehab,” or “intensive outpatient drug rehab (IOP),” the resource provides essential guidance on navigating insurance coverage and choosing the right level of care.
WhiteSands’ continued focus on clinical integrity, patient accessibility, and adherence to national treatment standards positions it among reputable providers working to reduce the treatment gap nationwide. Through resources such as this, the organization helps patients take an informed step toward recovery while addressing one of the most common barriers—understanding insurance coverage for addiction treatment.
###
For more information about WhiteSands Alcohol & Drug Rehab Orlando, contact the company here:
WhiteSands Alcohol & Drug Rehab Orlando Ryan Monesson (407) 255-2351 rmonesson@wstreatment.com 56 E Pine St, Orlando, FL 32801
NEW CANAAN, CT / ACCESS Newswire / November 6, 2025 / Network-1 Technologies, Inc. (NYSE American:NTIP), a company specializing in the acquisition, development, licensing, and monetization of its intellectual property assets, today announced financial results for the quarter ended September 30, 2025.
Network-1 reported no revenue for the three month periods ended September 30, 2025 and 2024. For the nine month periods ended September 30, 2025 and 2024, Network-1 reported revenue of $150,000 and $100,000, respectively. The revenue for the nine months ended September 30, 2025 and 2024 was from settlements of litigation relating to Network-1’s Remote Power Patent.
Network-1 reported a net loss of $560,000 or $0.02 per share basic and diluted for the three months ended September 30, 2025 compared with a net loss of $316,000 or $0.01 per share basic and diluted for the three months ended September 30, 2024. Included in the net loss is Network-1’s share of the net loss of its equity method investee of $354,000 and $308,000 for the three months ended September 30, 2025 and 2024, respectively
Network-1 realized a net loss of $1,386,000 or $0.06 per share basic and diluted for the nine months ended September 30, 2025 compared with a net loss of $1,894,000 or $0.08 per share basic and diluted for the nine months ended September 30, 2024. Included in the net loss is Network-1’s share of the net loss of its equity method investee of $1,095,000 and $1,613,000, respectively, during the nine months ended September 30, 2025 and 2024.
On September 8, 2025, Network-1’s wholly owned subsidiary, HFT Solutions, LLC, commenced patent litigation againstOptiverUS LLC and Optiver Trading US LLC in the United States District Court for the Western District of Texas for infringement of certain patents within the HFT Patent Portfolio. The HFT Patent Portfolio relates to, among other things, technologies used by firms engaged in high frequency trading activities that utilize field-programmable gate array (FPGA) hardware, including clock domain management technology that provides critical transaction latency gains in trading systems where the difference between success and failure may be measured in nanoseconds.
At September 30, 2025, Network-1 had cash and cash equivalents and marketable securities of $37,097,000 and working capital of $36,856,000. Network-1 believes based on its current cash position it will have sufficient cash to fund its operations for the next twelve months and the foreseeable future.
During the three months ended September 30, 2025, Network-1 repurchased an aggregate of 56,705 shares of its common stock at an aggregate cost of $78,428 (exclusive of commissions and excise taxes) or an average per share price of $1.38. During the nine months ended September 30, 2025, Network-1 repurchased an aggregate of 208,178 shares of its common stock at an aggregate cost of $280,623 (exclusive of commissions and excise taxes) or an average per share price of $1.35. At September 30, 2025, the remaining dollar value of shares that may be repurchased under the Share Repurchase Program was $4,916,425. Since the inception of the Share Repurchase Program through September 30, 2025, Network-1 has repurchased an aggregate of 10,582,410 shares of its common stock at an aggregate cost of $20,263,978 (exclusive of commissions and excise taxes) or an average per share price of $1.91.
Network‑1 continues to pay dividends consistent with its dividend policy, which consists of semi-annual cash dividends of $0.05 per share ($0.10 per share annually) which are anticipated to be paid in March and September of each year. On September 5, 2025, the Board of Directors of Network-1 declared a semi-annual cash dividend of $0.05 per common share which was paid on September 29, 2025 to all common stockholders of record as of September 19, 2025. Network-1’s dividend policy undergoes a periodic review by the Board of Directors and is subject to change at any time depending upon Network-1’s earnings, financial requirements and other factors existing at the time.
ABOUT NETWORK-1 TECHNOLOGIES, INC.
Network-1 Technologies, Inc. is engaged in the acquisition, development, licensing and protection of its intellectual property and proprietary technologies. Network-1 works with inventors and patent owners to assist in the development and monetization of their patented technologies. Network-1 currently owns one-hundred fifteen (115) U.S. patents and seventeen (17) international patents covering various technologies, including enabling technology for authenticating and using eSIM technology in Internet of Things (“IoT”) Machine-to-Machine and other mobile devices, certain advanced technologies related to high frequency trading, technologies relating to document stream operating systems and the identification of media content and enabling technology to support, among other things, the interoperability of smart home IoT devices. Network-1’s current strategy includes efforts to monetize four patent portfolios (the M2M/IoT, HFT, Cox and Smart Home portfolios). Network-1’s strategy is to focus on acquiring and investing in high quality patents which management believes have the potential to generate significant licensing opportunities as Network-1 has achieved with respect to its Remote Power Patent and Mirror Worlds Patent Portfolio. Network-1’s Remote Power Patent has generated licensing revenue in excess of $188,000,000 from May 2007 through September 30, 2025. Network-1 has achieved licensing and other revenue of $47,150,000 through September 30, 2025 with respect to its Mirror Worlds Patent Portfolio.
This release contains forward-looking statements within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. These statements address future events and conditions concerning Network-1’s business plans. Such statements are subject to a number of risk factors and uncertainties as disclosed in the Network-1’s Annual Report on Form 10-K for the year ended December 31, 2024 filed with the Securities and Exchange Commission on February 28, 2025and its Quarterly Report on Form 10-Q for the three months ended September 30, 2025 filed with the SEC on November 6, 2025 including, among others, Network-1’s uncertain revenue from licensing its intellectual property, uncertainty as to the outcome of pending litigation involving Network-1’s HFT Patent Portfolio and its M2M/IoT Patent Portfolio, whether Network-1 will be successful in its appeal to the Federal Circuit of the District Court judgment of non-infringement dismissing Network-1’s litigation against Google and YouTube involving certain patents within its Cox Patent Portfolio, the ability of Network-1 to successfully execute its strategy to acquire or make investments in high quality patents with significant licensing opportunities, Network-1’s ability to achieve revenue and profits from its Cox Patent Portfolio, M2M/IoT Patent Portfolio, HFT Patent Portfolio and Smart Home Portfolio, as well as a successful outcome on its investment in ILiAD Biotechnologies, LLC or other intellectual property it may acquire or finance in the future, the ability of Network-1 to enter into additional license agreements, uncertainty as to whether cash dividends will continue to be paid, Network-1’s ability to enter into strategic relationships with third parties to license or otherwise monetize their intellectual property, the risk in the future of Network-1 being classified as a Personal Holding Company which may result in Network-1 issuing a special cash dividend to its stockholders, future economic conditions and technology changes and legislative, regulatory and competitive developments. Except as otherwise required to be disclosed in periodic reports, Network-1 expressly disclaims any future obligation or undertaking to update or revise any forward-looking statement contained herein.
Network-1’s unaudited condensed consolidated statements of operations and condensed consolidated balance sheet are attached.
For additional details regarding the above referenced highlights, please see Network-1’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2025 filed with the SEC on November 6, 2025.
NETWORK-1 TECHNOLOGIES, INC. CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)
Three Months Ended September 30,
Nine Months Ended September 30,
2025
2024
2025
2024
REVENUE
$
–
$
–
$
150,000
$
100,000
OPERATING EXPENSES:
Costs of revenue
–
–
42,000
28,000
Professional fees and related costs
226,000
290,000
511,000
656,000
General and administrative
537,000
576,000
1,658,000
1,764,000
Amortization of patents
37,000
30,000
104,000
90,000
TOTAL OPERATING EXPENSES
800,000
896,000
2,315,000
2,538,000
OPERATING LOSS
(800,000
)
(896,000
)
(2,165,000
)
(2,438,000
)
OTHER INCOME:
Interest and dividend income, net
467,000
524,000
1,396,000
1,407,000
Net realized and unrealized gain on marketable securities
44,000
293,000
215,000
395,000
Total other income, net
511,000
817,000
1,611,000
1,802,000
LOSS BEFORE INCOME TAXES AND SHARE OF NET LOSSES OF EQUITY METHOD INVESTEE
(289,000
)
(79,000
)
(554,000
)
(636,000
)
INCOME TAXES PROVISION:
Current
–
–
(31,000
)
–
Deferred taxes, net
(83,000
)
(71,000
)
(232,000
)
(355,000
)
Total income tax benefit
(83,000
)
(71,000
)
(263,000
)
(355,000
)
LOSS BEFORE SHARE OF NET LOSS OF EQUITY METHOD INVESTEE:
(206,000
)
(8,000
)
(291,000
)
(281,000
)
SHARE OF NET LOSS OF EQUITY METHOD INVESTEE
(354,000
)
(308,000
)
(1,095,000
)
(1,613,000
)
NET LOSS
$
(560,000
)
$
(316,000
)
$
(1,386,000
)
$
(1,894,000
)
Net loss per share
Basic
$
(0.02
)
$
(0.01
)
$
(0.06
)
$
(0.08
)
Diluted
$
(0.02
)
$
(0.01
)
$
(0.06
)
$
(0.08
)
Weighted average common shares outstanding:
Basic
22,807,916
23,126,480
22,858,180
23,337,716
Diluted
22,807,916
23,126,480
22,858,180
23,337,716
Cash dividends declared per share
$
0.05
$
0.05
$
0.10
$
0.10
NETWORK-1 TECHNOLOGIES, INC. CONDENSED CONSOLIDATED BALANCE SHEETS
September 30,
2025
December 31,
2024
ASSETS
(Unaudited)
CURRENT ASSETS:
Cash and cash equivalents
$
7,708,000
$
13,145,000
Marketable securities, at fair value
29,389,000
27,455,000
Other current assets
166,000
232,000
TOTAL CURRENT ASSETS
37,263,000
40,832,000
OTHER ASSETS:
Patents, net of accumulated amortization
1,516,000
1,205,000
Equity investment
2,242,000
3,337,000
Operating leases right-of-use asset
–
27,000
Security deposit
13,000
13,000
Total Other Assets
3,771,000
4,582,000
TOTAL ASSETS
$
41,034,000
$
45,414,000
LIABILITIES AND STOCKHOLDERS’ EQUITY:
CURRENT LIABILITIES:
Accounts payable
$
220,000
$
203,000
Accrued payroll
–
292,000
Other accrued expenses
187,000
247,000
Operating lease obligations
–
24,000
Total Current Liabilities
407,000
766,000
LONG TERM LIABILITIES:
Deferred tax liability
105,000
337,000
TOTAL LIABILITIES
512,000
1,103,000
COMMITMENTS AND CONTINGENCIES (Note G)
STOCKHOLDERS’ EQUITY
Preferred stock, $0.01 par value, authorized 10,000,000 shares; none issued and outstanding at September 30, 2025 and December 31, 2024
–
–
Common stock, $0.01 par value; authorized 50,000,000 shares; 22,820,593 and 22,961,619 shares issued and outstanding at September 30, 2025 and December 31, 2024, respectively
228,000
229,000
Additional paid-in capital
63,346,000
65,455,000
Accumulated deficit
(23,052,000
)
(21,373,000
)
TOTAL STOCKHOLDERS’ EQUITY
40,522,000
44,311,000
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY
$
41,034,000
$
45,414,000
Contact:
Corey M. Horowitz, Chairman and CEO Network-1 Technologies, Inc. (203) 920-1055 (917) 692-0000
